MoveMD

product on market Capsule 1MD Nutrition Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 40% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The formula includes collagen and hyaluronic acid, which have moderate evidence for supporting joint structure and lubrication. ApresFLEX and Zanthin are included for joint health, though clinical evidence for these specific branded ingredients is limited. The profile maintains a high safety rating with no significant concerns noted.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for MoveMD
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
40%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

ApresFLEX
100 mg
Zanthin
2 mg
100 mg
Market median: 20.0mg (931 products) 234 studies (A:1, B:90)
Market median: 20.0mg (931 products) 234 studies (A:1, B:90)
Market median: 100.0mg (173 products)

Other Ingredients

Vegetable Cellulose Capsule Vegetable Oil powder Silica
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: As a dietary supplement, adults take one (1) capsule, once (1x) daily, or as recommended by a healthcare practitioner.

Warnings & Precautions

Warning: Consult a healthcare practitioner if you are pregnant or nursing, have a serious medical condition, or use any medications.

Keep out of reach of children.

Do not use if safety seal is damaged or missing.

Contains eggs.

Formulation Notes

Color may vary.

Wheat-free Dairy-free Peanut-free Shellfish-free

Comprehensive joint support Promotes joint mobility & flexibility Supports joint comfort Aids proper joint function

Manufactured in the USA from globally-sourced ingredients.

Additional Information

Store in a cool, dry place.

GMP Good Manufacturing Practice

1MD MoveMD - Joint ... More | 30 capsules New

Metadata

Product Details

UPC / SKUX002YS2CJJ
DSLD Entry Date2022-11-22
Product TypeOther Combinations
FormCapsule
DSLD ID274803
Data Updated2026-04-11
Research

Research Evidence

14
Research Sources
50
Avg Quality
9
Rct
3
Clinical Trial
1
Systematic Review
1
Guideline
B Dressings and topical agents containing hyaluronic acid for chronic wound healing
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
B Effect of laughter exercise versus 0.1% sodium hyaluronic acid on ocular surface discomfort in dry eye disease: non-inferiority randomised controlled trial
Rct BMJ (Clinical research ed.) 2024 PubMed DOI
B Expert consensus on hyaluronic acid injections for knee osteoarthritis: a patient-centered approach.
Guideline Aging clinical and experimental research 2026 PubMed DOI
C The Effects of Dietary Supplementation with Collagen and Vitamin C and Their Combination with Hyaluronic Acid on Skin Density, Texture and Other Parameters: A Randomised, Double-Blind, Placebo-Controlled Trial
Rct Nutrients 2024 PubMed DOI
C Effects of ozone combined with articular injection of sodium hyaluronate on patients with knee osteoarthritis and their inflammatory factors and hemorheological indices.
Rct African health sciences PubMed DOI
C The effect of oral low molecular weight liquid hyaluronic acid combination with glucosamine and chondroitin on knee osteoarthritis patients with mild knee pain: An 8-week randomized double-blind placebo-controlled trial.
Rct Medicine PubMed DOI
C Liquid combination of hyaluronan, glucosamine, and chondroitin as a dietary supplement for knee osteoarthritis patients with moderate knee pain: A randomized controlled study.
Rct Medicine PubMed DOI
C Oral preparation of hyaluronic acid, chondroitin sulfate, N-acetylglucosamine, and vitamin C improves sexual and urinary symptoms in participants with recurrent urinary tract infections: a randomized crossover trial.
Rct The journal of sexual medicine PubMed DOI
C PMCF Study to Evaluate Performance and Safety of 'Hyaluronic Acid (HA)-Based Eyedrops' Used to Relieve Dry Eye Symptoms
Clinical Trial ClinicalTrials.gov 2022
C Effect of Hyaluronic Acid Oral Supplementation on Sexual and Urinary Symptoms of Women With Recurrent Urinary Tract Infections
Clinical Trial ClinicalTrials.gov 2022
View all evidence for Hyaluronic Acid →
Compare

Similar Products

View all Hyaluronic Acid products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.